Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ejmech.2011.01.020
DC FieldValue
dc.titleExploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitors
dc.contributor.authorZhang, C.
dc.contributor.authorTan, C.
dc.contributor.authorZu, X.
dc.contributor.authorZhai, X.
dc.contributor.authorLiu, F.
dc.contributor.authorChu, B.
dc.contributor.authorMa, X.
dc.contributor.authorChen, Y.
dc.contributor.authorGong, P.
dc.contributor.authorJiang, Y.
dc.date.accessioned2014-10-29T01:52:45Z
dc.date.available2014-10-29T01:52:45Z
dc.date.issued2011-04
dc.identifier.citationZhang, C., Tan, C., Zu, X., Zhai, X., Liu, F., Chu, B., Ma, X., Chen, Y., Gong, P., Jiang, Y. (2011-04). Exploration of (S)-3-aminopyrrolidine as a potentially interesting scaffold for discovery of novel Abl and PI3K dual inhibitors. European Journal of Medicinal Chemistry 46 (4) : 1404-1414. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ejmech.2011.01.020
dc.identifier.issn02235234
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/105942
dc.description.abstractBased on the literature-reported compensatory effect of PI3K on Abl inhibition and the improved preclinical effect of drug combination of Abl and PI3K inhibitors, a series of compounds bearing novel scaffold of (S)-3-aminopyrrolidine was identified as Abl and PI3K dual inhibitors through support vector machine screening tool, which were subsequently synthesized and tested. Most compounds demonstrated promising cytoxicity against a CML leukemia cell-line K562 and moderate inhibition against Abl and PI3K kinases. These compounds induced no apoptosis in K562 cell-line, suggesting that their cytotoxic activities are unlikely duo to other known anti-CML mechanisms. Molecular docking study further showed that the compound 5k could bind with both Abl and PI3K, but the weaker binding with Abl compared to Imatinib is consistent with its low kinase inhibitory rates. These plus literature-reported evidences suggest that the promising cytotoxic effect of our novel compounds might be due to the collective effect of Abl and PI3K inhibition. © 2011 Elsevier Masson SAS. All rights reserved.
dc.description.urihttp://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1016/j.ejmech.2011.01.020
dc.sourceScopus
dc.subject(S)-3-Aminopyrrolidine
dc.subjectAbl
dc.subjectDual kinase inhibitor
dc.subjectK562
dc.subjectPI3K
dc.typeArticle
dc.contributor.departmentPHARMACY
dc.description.doi10.1016/j.ejmech.2011.01.020
dc.description.sourcetitleEuropean Journal of Medicinal Chemistry
dc.description.volume46
dc.description.issue4
dc.description.page1404-1414
dc.description.codenEJMCA
dc.identifier.isiut000289048400045
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.